Indivior PLC (LON:INDV – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 805.29 ($10.39) and traded as low as GBX 714 ($9.21). Indivior shares last traded at GBX 733 ($9.46), with a volume of 401,184 shares changing hands.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,800 ($23.22) target price on shares of Indivior in a research report on Tuesday, December 17th.
View Our Latest Analysis on Indivior
Indivior Trading Down 2.6 %
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- The 3 Best Retail Stocks to Shop for in August
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Differences Between Momentum Investing and Long Term Investing
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.